Thousands of breast cancer patients could avoid gruelling chemotherapy thanks to research carried out by a Welsh surgeon.
Simon Holt, a breast surgeon at Hywel Dda Local Health Board, led a study into a new test to help determine whether a breast cancer patient needs to have the treatment.
The National Institute for Health and Care Excellence (NICE) has approved the 'Oncotype DX' test, which is used in people with certain types of genes and who are assessed as being at intermediate risk of their cancer spreading.
The test measures the presence of biological characteristics in the tumour which may show how likely it is to grow and whether it is likely to spread. Combined with other clinical information, the test will help determine which patients are most suitable for chemotherapy.
More top news
The turtle broke records when she was found to have landed in British waters after being carried over 8000 miles.
Barry Rogers is on trial along with his mother for the murder of his 84-year-old grandmother Betty Guy in 2011.
Following his exclusion from the Plaid Cymru group of AMs, Neil McEvoy has claimed that a lobbying company were behind complaints about him.